Table of Content

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to mRNA Vaccines Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Growing Diverse Applications of mRNA Post COVID-19 Vaccine Success
3.2.1.2 Significant Research Funding to Boost Market Growth
3.2.1.3 Technological Advances Driving the Market Growth
3.2.1.4 Rising mRNA Vaccine-based Clinical Trials
3.2.2 Market Restraining Factors
3.2.2.1 Scalability and Cost-Effectiveness is Still a Major Bottleneck
3.2.2.2 Significant Storage Challenges in Low-income Countries Likely to Challenge Industry Growth
3.2.3 Market Opportunities
3.2.3.1 mRNA Cancer Vaccines
3.2.3.2 Analytics, Machine Learning and Cloud Data Warehousing
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors

4 mRNA Vaccines Market Analysis by Vaccine Type
4.1 Key Findings
4.2 Vaccine Type Segment: Market Attractiveness Index
4.3 mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
4.4 Self-amplifying mRNA-based Vaccines
4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Conventional Non-amplifying mRNA-based Vaccines
4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)

5 mRNA Vaccines Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 mRNA Vaccines Market Size Estimation and Forecast by Application
5.4 Cancer
5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Infectious Disease
5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Autoimmune Diseases
5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Others
5.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)

6 mRNA Vaccines Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 mRNA Vaccines Market Size Estimation and Forecast by End-users
6.4 Hospitals and Clinics
6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Research Organisations
6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Others
6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)

7 mRNA Vaccines Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America mRNA Vaccines Market Analysis
8.1 Key Findings
8.2 North America mRNA Vaccines Market Attractiveness Index
8.3 North America mRNA Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
8.4 North America mRNA Vaccines Market Size Estimation and Forecast by Country
8.5 North America mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
8.6 North America mRNA Vaccines Market Size Estimation and Forecast by Application
8.7 North America mRNA Vaccines Market Size Estimation and Forecast by End-users
8.8 U.S. mRNA Vaccines Market Analysis
8.9 Canada mRNA Vaccines Market Analysis

9 Europe mRNA Vaccines Market Analysis
9.1 Key Findings
9.2 Europe mRNA Vaccines Market Attractiveness Index
9.3 Europe mRNA Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 Europe mRNA Vaccines Market Size Estimation and Forecast by Country
9.5 Europe mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
9.6 Europe mRNA Vaccines Market Size Estimation and Forecast by Application
9.7 Europe mRNA Vaccines Market Size Estimation and Forecast by End-users
9.8 Germany mRNA Vaccines Market Analysis
9.9 UK mRNA Vaccines Market Analysis
9.10 France mRNA Vaccines Market Analysis
9.11 Italy mRNA Vaccines Market Analysis
9.12 Spain mRNA Vaccines Market Analysis
9.13 Russia mRNA Vaccines Market Analysis
9.14 Rest of Europe mRNA Vaccines Market Analysis

10 Asia Pacific mRNA Vaccines Market Analysis
10.1 Key Findings
10.2 Asia Pacific mRNA Vaccines Market Attractiveness Index
10.3 Asia Pacific mRNA Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Asia Pacific mRNA Vaccines Market Size Estimation and Forecast by Country
10.5 Asia Pacific mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
10.6 Asia Pacific mRNA Vaccines Market Size Estimation and Forecast by Application
10.7 Asia Pacific mRNA Vaccines Market Size Estimation and Forecast by End-users
10.8 Japan mRNA Vaccines Market Analysis
10.9 China mRNA Vaccines Market Analysis
10.10 India mRNA Vaccines Market Analysis
10.11 Australia mRNA Vaccines Market Analysis
10.12 South Korea mRNA Vaccines Market Analysis
10.13 South-East Asia mRNA Vaccines Market Analysis
10.14 Rest of Asia Pacific mRNA Vaccines Market Analysis

11 Latin America mRNA Vaccines Market Analysis
11.1 Key Findings
11.2 Latin America mRNA Vaccines Market Attractiveness Index
11.3 Latin America mRNA Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Latin America mRNA Vaccines Market Size Estimation and Forecast by Country
11.5 Latin America mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
11.6 Latin America mRNA Vaccines Market Size Estimation and Forecast by Application
11.7 Latin America mRNA Vaccines Market Size Estimation and Forecast by End-users
11.8 Brazil mRNA Vaccines Market Analysis
11.9 Mexico mRNA Vaccines Market Analysis
11.10 Rest of Latin America mRNA Vaccines Market Analysis

12 MEA mRNA Vaccines Market Analysis
12.1 Key Findings
12.2 MEA mRNA Vaccines Market Attractiveness Index
12.3 MEA mRNA Vaccines Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 MEA mRNA Vaccines Market Size Estimation and Forecast by Country
12.5 MEA mRNA Vaccines Market Size Estimation and Forecast by Vaccine Type
12.6 MEA mRNA Vaccines Market Size Estimation and Forecast by Application
12.7 MEA mRNA Vaccines Market Size Estimation and Forecast by End-users
12.8 GCC mRNA Vaccines Market Analysis
12.9 South Africa mRNA Vaccines Market Analysis
12.10 Rest of MEA mRNA Vaccines Market Analysis

13 Company Profiles
13.1 Pfizer Inc.
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2015-2022
13.1.3.2 Regional Market Shares, 2022
13.1.3.3 R&D, 2015-2022
13.1.4 Product/Pipeline Benchmarking
13.1.5 Strategic Outlook
13.2 Moderna, Inc.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2016-2022
13.2.3.2 R&D, 2016-2022
13.2.4 Product/Pipeline Benchmarking
13.2.5 Strategic Outlook
13.3 BioNTech SE
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2018-2022
13.3.3.2 R&D, 2018-2022
13.3.4 Product/Pipeline Benchmarking
13.3.5 Strategic Outlook
13.4 GSK plc
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2022
13.4.3.2 Regional Market Shares, 2022
13.4.3.3 R&D, 2015-2022
13.4.4 Product/Pipeline Benchmarking
13.5 Daiichi Sankyo
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Product/Pipeline Benchmarking
13.5.4 Strategic Outlook
13.6 Ethris GmbH
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product/Pipeline Benchmarking
13.6.4 Strategic Outlook
13.7 AIM Vaccine
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product/Pipeline Benchmarking
13.7.4 Strategic Outlook
13.8 Arcturus Therapeutics Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product/Pipeline Benchmarking
13.9 CureVac
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product/Pipeline Benchmarking
13.9.4 Strategic Outlook
13.10 AstraZeneca
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2015-2022
13.10.3.2 Regional Market Shares, 2022
13.10.3.3 R&D, 2015-2022
13.10.4 Product/Pipeline Benchmarking
13.10.5 Strategic Outlook
13.11 Sanofi
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2018-2022
13.11.3.2 Regional Market Shares, 2022
13.11.3.3 R&D, 2018-2022
13.11.4 Product/Pipeline Benchmarking
13.12 Sino Biopharmaceutical Co., Ltd.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Product/Pipeline Benchmarking

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 mRNA Vaccines Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 mRNA Vaccines & Therapeutics: Companies & Delivery Platforms
Table 3 mRNA Vaccines in Clinical Trials: June 2023
Table 4 mRNA Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
Table 5 mRNA Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
Table 6 mRNA Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
Table 7 mRNA Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
Table 8 mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Self-amplifying mRNA-based Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Conventional Non-amplifying mRNA-based Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Hospitals and Clinics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Research Organisations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 mRNA Vaccines Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 North America mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 North America mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 North America mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 North America mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 U.S. mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Canada mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Europe mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 Europe mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 Europe mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 Europe mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 Germany mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 UK mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 France mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 Italy mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Spain mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Russia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Rest of Europe mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Asia Pacific mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Asia Pacific mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Asia Pacific mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Asia Pacific mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Japan mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 China mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 India mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Australia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 South Korea mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 South-East Asia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Asia Pacific mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Latin America mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Latin America mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Latin America mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Brazil mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Mexico mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Rest of Latin America mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 MEA mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 MEA mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 MEA mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 MEA mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 GCC mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South Africa mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of MEA mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Pfizer Inc.: Product/Pipeline Benchmarking
Table 64 Pfizer Inc.: Strategic Outlook
Table 65 Moderna, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Moderna, Inc.: Product/Pipeline Benchmarking
Table 67 Moderna, Inc.: Strategic Outlook
Table 68 BioNTech SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 BioNTech SE: Product/Pipeline Benchmarking
Table 70 BioNTech SE: Strategic Outlook
Table 71 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 GSK plc: Product/Pipeline Benchmarking
Table 73 Daiichi Sankyo: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Daiichi Sankyo: Product/Pipeline Benchmarking
Table 75 Daiichi Sankyo: Strategic Outlook
Table 76 Ethris GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Ethris GmbH: Product/Pipeline Benchmarking
Table 78 Ethris GmbH: Strategic Outlook
Table 79 AIM Vaccine: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 AIM Vaccine: Product/Pipeline Benchmarking
Table 81 AIM Vaccine: Strategic Outlook
Table 82 Arcturus Therapeutics Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Arcturus Therapeutics Inc.: Product/Pipeline Benchmarking
Table 84 CureVac: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 CureVac: Product/Pipeline Benchmarking
Table 86 CureVac: Strategic Outlook
Table 87 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 AstraZeneca: Product/Pipeline Benchmarking
Table 89 AstraZeneca: Strategic Outlook
Table 90 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Sanofi: Product/Pipeline Benchmarking
Table 92 Sino Biopharmaceutical Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Sino Biopharmaceutical Co., Ltd.: Product/Pipeline Benchmarking
 
List of Figures
Figure 1 mRNA Vaccines Market Segmentation
Figure 2 mRNA Vaccines Market by Vaccine Type: Market Attractiveness Index
Figure 3 mRNA Vaccines Market by Application: Market Attractiveness Index
Figure 4 mRNA Vaccines Market by End-users: Market Attractiveness Index
Figure 5 mRNA Vaccines Market Attractiveness Index by Region
Figure 6 mRNA Vaccines Market: Market Dynamics
Figure 7 mRNA Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “V” Shaped Recovery
Figure 8 mRNA Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “U” Shaped Recovery
Figure 9 mRNA Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “W” Shaped Recovery
Figure 10 mRNA Vaccines Market by Region, 2023-2033 (US$ Million, AGR %): “L” Shaped Recovery
Figure 11 mRNA Vaccines Market: Porter’s Five Forces Analysis
Figure 12 mRNA Vaccines Market: PEST Analysis
Figure 13 mRNA Vaccines Market Attractiveness Index by Vaccine Type
Figure 14 mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 15 mRNA Vaccines Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
Figure 16 Self-amplifying mRNA-based Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 17 Self-amplifying mRNA-based Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 18 Conventional Non-amplifying mRNA-based Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 19 Conventional Non-amplifying mRNA-based Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 mRNA Vaccines Market Attractiveness Index by Vaccine Type
Figure 21 mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 22 mRNA Vaccines Market Share Forecast by Application, 2023, 2028, 2033 (%)
Figure 23 Cancer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 24 Cancer Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 26 Infectious Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Autoimmune Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 28 Autoimmune Diseases Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 30 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 mRNA Vaccines Market Attractiveness Index by End-users
Figure 32 mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 33 mRNA Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 34 Hospitals and Clinics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 35 Hospitals and Clinics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Research Organisations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 37 Research Organisations Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 40 mRNA Vaccines Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 41 mRNA Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 42 mRNA Vaccines Market by Region, 2023-2033 (US$ Mn)
Figure 43 North America mRNA Vaccines Market Attractiveness Index
Figure 44 North America mRNA Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 45 North America mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 46 North America mRNA Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 47 North America mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 48 North America mRNA Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 49 North America mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 50 North America mRNA Vaccines Market Share Forecast by Application, 2023 & 2033 (%)
Figure 51 North America mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 52 North America mRNA Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 53 U.S. mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 54 Canada mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 Europe mRNA Vaccines Market Attractiveness Index
Figure 56 Europe mRNA Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 57 Europe mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 58 Europe mRNA Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 59 Europe mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe mRNA Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 61 Europe mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe mRNA Vaccines Market Share Forecast by Application, 2023 & 2033 (%)
Figure 63 Europe mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 64 Europe mRNA Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 65 Germany mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 UK mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 67 France mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 68 Italy mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 Spain mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 70 Russia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 71 Rest of Europe mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 Asia Pacific mRNA Vaccines Market Attractiveness Index
Figure 73 Asia Pacific mRNA Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 74 Asia Pacific mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ million, AGR %)
Figure 75 Asia Pacific mRNA Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 Asia Pacific mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 77 Asia Pacific mRNA Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 78 Asia Pacific mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 79 Asia Pacific mRNA Vaccines Market Share Forecast by Application, 2023 & 2033 (%)
Figure 80 Asia Pacific mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 81 Asia Pacific mRNA Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 82 Japan mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 China mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 84 India mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 85 Australia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 86 South Korea mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 South-East Asia mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Rest of Asia Pacific mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 89 Latin America mRNA Vaccines Market Attractiveness Index
Figure 90 Latin America mRNA Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 91 Latin America mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 92 Latin America mRNA Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 93 Latin America mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 94 Latin America mRNA Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 95 Latin America mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 96 Latin America mRNA Vaccines Market Share Forecast by Application, 2023 & 2033 (%)
Figure 97 Latin America mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 98 Latin America mRNA Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 99 Brazil mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Mexico mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Latin America mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 102 MEA mRNA Vaccines Market Attractiveness Index
Figure 103 MEA mRNA Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 104 MEA mRNA Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 105 MEA mRNA Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 MEA mRNA Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
Figure 107 MEA mRNA Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 108 MEA mRNA Vaccines Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
Figure 109 MEA mRNA Vaccines Market Share Forecast by Application, 2023 & 2033 (%)
Figure 110 MEA mRNA Vaccines Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 111 MEA mRNA Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 112 GCC mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 113 South Africa mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 114 Rest of MEA mRNA Vaccines Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Pfizer Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 116 Pfizer Inc.: Regional Market Shares (%), 2022
Figure 117 Pfizer Inc.: R&D, 2015-2022 (US$ million, AGR%)
Figure 118 Moderna, Inc.: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 119 Moderna, Inc.: R&D, 2016-2022 (US$ million, AGR%)
Figure 120 BioNTech SE: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 121 BioNTech SE: R&D, 2018-2022 (US$ million, AGR%)
Figure 122 GSK plc: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 123 GSK plc: Regional Market Shares (%), 2022
Figure 124 GSK plc: R&D, 2015-2022 (US$ million, AGR%)
Figure 125 AstraZeneca: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 126 AstraZeneca: Regional Market Shares (%), 2022
Figure 127 AstraZeneca: R&D, 2015-2022 (US$ million, AGR%)
Figure 128 Sanofi: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 129 Sanofi: Regional Market Shares (%), 2022
Figure 130 Sanofi: R&D, 2018-2022 (US$ million, AGR%)